Jeffrey Hunt, MD
Otolaryngology · Kingsport, TNNPI 1255334298
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.1% of the total. Reporting peaked in 2021 at $268 and has fallen 59.1% since, to $110 in 2025. That places this record below the midpoint for otolaryngology clinicians in TN, where the typical reported total is $1,839.
Across 72 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$405
- GSK$334
- Stryker$218
- Sanofi$207
- Tris Pharma Inc$70
- Integra Lifesciences Corporation$51
- plus $209 from 9 others
Across 11 payments — averaging $3756.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$41K
What the payments were for
- Food & beverage$1,43396%
- Education$624%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $405 |
| GSK | 18 | $334 |
| Stryker | 9 | $218 |
| Sanofi | 9 | $207 |
| Tris Pharma Inc | 4 | $70 |
| Integra Lifesciences Corporation | 2 | $51 |
| Optinose US, Inc. | 2 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Aerin Medical Inc. | 2 | $30 |
| Pfizer | 2 | $29 |
| Tactile Systems Technology Inc | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Ambu Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$1,494 in reported general payments places this provider in the 40th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 176 | $5,012 |
| Fluticasone Propionate | 232 | $3,017 |
| Ofloxacin | 56 | $2,204 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 16 | $1,956 |
| Azelastine Hcl | 57 | $1,762 |
| Fluocinolone Acetonide Oil | 35 | $1,381 |
| Clotrimazole | 23 | $1,373 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 58 | $752 |
| Omeprazole | 40 | $550 |
| Doxycycline Hyclate | 50 | $541 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $498 |
| Montelukast Sodium | 47 | $456 |
| Moxifloxacin Hcl | 13 | $437 |
| Fluconazole | 23 | $416 |
| Betamethasone Dipropionate | 15 | $405 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kingsport
- David OsterhusKingsport$4K
- David CowdenKingsport$3K
- Rakesh ChandraNashville$381K
- David FortuneHermitage$298K
- Grady BryantHermitage$74K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
- Michael TopfNashville$36K
- John GleysteenMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.